|
Dr. Susan Hall heads Global Regulatory Sciences with responsibility for Regulatory Affairs and Compliance, Pharmacovigilance, Data Management and Medical Writing. She has extensive multi disciplinary and international experience spanning 23 years in drug development and life cycle management across a broad range of therapeutic areas, including Anti-Infectives, CNS, Dermatology, Cardiovascular, Respiratory and Metabolic, as well as specialized expertise in Genomics. Dr. Hall initially worked at Beecham Pharmaceuticals within the Pharmacokinetics Unit and then subsequently joined GlaxoSmithKline in the department of Clinical Pharmacology, based in the United Kingdom. In 1992, Dr. Hall moved to the U.S and has held various management positions within GlaxoSmithKline including Clinical Pharmacology, Project Management, and most recently, Regulatory Affairs. Dr. Hall has managed global projects across the drug development continuum from Research to Commercial and brings substantial project management, regulatory and drug discovery expertise as well as significant international regulatory dossier experience. Dr. Hall holds a B.S. degree in Pharmacology from the University of Leeds, United Kingdom, and a Ph.D. in Pharmacokinetics from the Department of Pharmacy, University of Manchester, United Kingdom. | 